Composite Endpoints in Cardio-Renal Clinical Outcome Trials

References

• Akacha, M., Binkowitz, B., Claggett, B., Hung, H. M. J., Mueller-Velten, G., and Stockbridge, N. (2019), “Assessing Treatment Effects that Capture Disease Burden in Serious Chronic Diseases,” Therapeutic Innovation & Regulatory Science, 53, 387–397.
   PubMed Web of Science ®Google Scholar
• Andersen, P.K. and Gill, R.D. (1982), “Cox’s Regression Model for Counting Processes: A Large Sample Study,” Annals of Statics, 10, 1100–1120.
   Web of Science ®Google Scholar
• Brenner, B. A., Cooper, M. E., de Zeenw, D., Keane, W. F., Mitch, W. E., Parying, H.-H., Remuzzi, G., Snapinn, S. M., Zhang, Z., and Shahinfar, S. for the RENAAL Study Investigators (2001), “Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy,” New England Journal of Medicine, 345, 861–869. DOI: 10.1056/NEJMoa011161.
   PubMed Web of Science ®Google Scholar
• Buyse, M. (2010), “Generalized Pairwise Comparisons of Prioritized Outcomes in the Two-Sample Problem,” Statistics in Medicine, 29, 3245–3257. DOI: 10.1002/sim.3923.
   PubMed Web of Science ®Google Scholar
• Chen, Y., Lawrence, J., and Stockbridge, N. (2021), “Days Alive Out of Hospital in Heart Failure: Insights from the PARADIGM-HF and CHARM Trials,” American Heart Journal. DOI: 10.1016/j.ahj.2021.03.016.
   Web of Science ®Google Scholar
• Cowling, B.J., Hutton, J.L., and Shaw, J.E.H. (2006), “Joint Modeling of Event Counts and Survival Times,” Applied Statistics, 55, 31–39.
   Web of Science ®Google Scholar
• Evans, S.R. and Follmann, D. (2016), “Using Outcomes to Analyze Patients Rather than Patients to Analyze Outcomes: A Step Toward Pragmatism in Benefit: Risk Evaluation”, Statistics in Biopharmaceutical Research, 8, 386–393. DOI: 10.1080/19466315.2016.1207561.
   PubMed Web of Science ®Google Scholar
• Finkelstein, D. M., and Schoenfeld, D. A. (1999), “Combining Mortality and Longitudinal Measures in Clinical Trials”, Statistics in Medicine, 18, 1341–1354. DOI: 10.1002/(SICI)1097-0258(19990615)18:11<1341::AID-SIM129>3.0.CO;2-7.
   PubMed Web of Science ®Google Scholar
• Follmann, D., Fay, M.P., Hamasaki, T., and Evans, S.R. (2020), “Analysis of Ordered Composite Endpoints,” Statistics in Medicine, 39, 602–615. DOI: 10.1002/sim.8431.
   PubMed Web of Science ®Google Scholar
• Ghosh, D., and Lin, D.Y. (2002), “Marginal Regression Models for Recurrent and Terminal Events,” Statistica Sinica, 12, 663–688.
   Web of Science ®Google Scholar
• Glasziou, P. P., Bromwich, S., and Simes, R.J. (1994), “Quality of Life Six Months After Myocardial Infarction Treated With Thrombolytic Therapy. AUS-TASK Group. Australian Arm of International tPA/SK Mortality Trial,” The Medical Journal of Australia,161.9, 532–536. DOI: 10.5694/j.1326-5377.1994.tb127596.x.
   PubMed Web of Science ®Google Scholar
• Guyatt, G. H., Sinclair, J., Cook, D.J., and Glasziou, P. (1999), “Users’ Guides to the Medical Literature: XVI. How to Use a Treatment Recommendation,” JAMA, 281.19, 1836–1843. DOI: 10.1001/jama.281.19.1836.
   PubMed Web of Science ®Google Scholar
• Hung, H. M. J., and Wang, S. J. (2013), “Multiple Comparisons in Complex Clinical Trial Designs,” Biometrical Journal, 55, 420–429. DOI: 10.1002/bimj.201200048.
   PubMed Web of Science ®Google Scholar
• International Council on Harmonisation (2019), ICH Final Concept Paper E9(R1): Addendum on Estimands and Sensitivity Analysis in Clinical Trials to the Guidelines on Statistical Principles for Clinical Trials, available at https://database.ich.org/sites/default/files/E9-R1_Step4_Guideline_2019_1203.pdf.
   Google Scholar
• Kaul, S., and Diamond, G.A. (2010), “Trial and Error: How to Avoid Commonly Encountered Limitations of Published Clinical Trials,” Journal of the American College of Cardiology, 55, 415–427. DOI: 10.1016/j.jacc.2009.06.065.
   PubMed Web of Science ®Google Scholar
• Liang, K., and Zeger, S. (1986), “Longitudinal Data Analysis Using Generalized Linear Models,” Biometrika, 73, 13–22. DOI: 10.1093/biomet/73.1.13.
   Web of Science ®Google Scholar
• Liu, L., and Wolfe, R.A., Huang, X. (2004), “Shared Frailty Models for Recurrent Events and Terminal Event,” Biometrics, 60, 747–756. DOI: 10.1111/j.0006-341X.2004.00225.x.
   PubMed Web of Science ®Google Scholar
• Mao, L., and Lin, D.Y. (2016), “Semiparametric Regression for the Weighted Composite Endpoint of Recurrent and Terminal Events,” Biostatistics, 17, 390–403. DOI: 10.1093/biostatistics/kxv050.
   PubMed Web of Science ®Google Scholar
• Pinto-Prades, J., Martinez-Pere J.z., and Abellán-Perpiñán, J. (2006), “The Influence of the Ratio Bias Phenomenon on the Elicitation of Health States Utilities,” Judgment and Decision Making, 1, 118–113.
   Web of Science ®Google Scholar
• Pocock, S.J., Ariti, C.A., Collier, T.J., and Wang, D. (2012), “The Win Ratio: A New Approach to the Analysis of Composite Endpoints in Clinical Trials Based on Clinical Priorities,” European Heart Journal, 33,176–182. DOI: 10.1093/eurheartj/ehr352.
   PubMed Web of Science ®Google Scholar
• Prentice, R. L., Williams, B. J., and Peterson, A. V. (1981), “On the Regression Analysis of Multivariate Failure Time Data,” Biometrika, 68, 373–379.
   Web of Science ®Google Scholar
• Qiu, J., Gu, E., Zhou, D., Bai, S., Lawrence, J., and Hung, H. M. J. (2019), “Estimation on Conditional Restricted Mean Survival Time with Counting Process,” Journal of Biopharmaceutical Statistics, 29, 800–809. DOI: 10.1080/10543406.2019.1657129.
   PubMed Web of Science ®Google Scholar
• Tung, R., Kaul, S., Diamond, G.A., and Shah, P.K. (2006), “Narrative Review: Drug-Eluting Stents for the Management of Restenosis: A Critical Appraisal of the Evidence,” Annals of Internal Medicine, 144, 913–919. DOI: 10.7326/0003-4819-144-12-200606200-00009.
   PubMed Web of Science ®Google Scholar
• Uno, H., Claggett, B., Tian, L., Inoue, E., Gallo, P., Miyata, T., Schrag, D., Takeuchi, M., Uyama, Y., Zhao, L., and Skali, H. (2014), “Moving Beyond the Hazard Ratio in Quantifying the Between-Group Difference in Survival Analysis,” Journal of Clinical Oncology, 32, 2380–2385. DOI: 10.1200/JCO.2014.55.2208.
   PubMed Web of Science ®Google Scholar
• Wei, L.J., Lin, D. and Weissfeld, L. (1989), “Regression Analysis of Multivariate Incomplete Failure Time Data by Modeling Marginal Distributions,” Journal of the American Statististical Association, 84, 1065–1073.
   Web of Science ®Google Scholar